Isolation of a novel gene mutated in Wiskott-Aldrich syndrome

Cell

Volumn 78, Issue 4, 1994, Pages 635-644

  Derry, Jonathan M J ^a   Ochs, Hans D ^b   Francke, Uta ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ECZEMA; GENE DELETION; GENE ISOLATION; GENE MUTATION; IMMUNE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; TRANSLATION REGULATION; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKAGE;

EID: 0027937223     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(94)90528-2     Document Type: Article

References (56)

1. Disorders of the T-cell system
2. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome
3. Identification of a protein that binds to the SH3 region of AN and is similar to Bcr and GAP-Rho
4. Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome
5. Nuclear targeting sequences—a consensus?
6. Hereditary X-linked thrombocytopenia maps to the same chromosomal region as the Wiskott-Aldrich syndrome
7. hnRNP proteins and the biogenesis of mRNA
8. Carrier detection in the Wiskott-Aldrich syndrome
9. Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich syndrome carrier
10. The isolation of cDNAs from OATL1 at Xp 112 using a 480-kb YAC
11. Transcriptional activation modulated by homopolymeric glutamine and proline stretches
12. The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription
13. Mutants of GAL4 protein altered in an activation function
14. Carrier detection in Wiskott-Aldrich syndrome combined use of M27 beta for X-inactivation studies and as a linked probe
15. Chromosomal region of the cystic fibrosis gene in yeast artificial chromosomes a model for human genome mapping
16. Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation
17. X-chromosome inactivation in the Wiskott-Aldrich syndrome a marker for detection of the carrier state and identification of cell lineages expressing the gene defect
18. Linkage relationships of the Wiskott-Aldrich syndrome to 10 loci in the pericentromeric region of the human X chromosome
19. The Wiskott-Aldrich syndrome refinement of the localization on Xp and identification of another closely linked marker locus OATL1
20. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome
21. Functional dissection of a eukaryotic transcriptional activator protein GCN4 of yeast
22. Stringent integrity requirements for both transactivation and DNA-binding in a trans-activator Oct3
23. Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation
24. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs
25. Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers
26. Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers TIMP and DXS255 on Xp1122-Xp113
27. A simple method for displaying the hydropathic character of a protein
28. Physical mapping of 60 DNA markers in the p211--q213 region of the human X chromosome
29. Direct selection a method for the isolation of cDNAs encoded by large genomic regions
30. Deletion analysis of GAL4 defines two transcriptional activating segments
31. Platelets
32. Regulated expression of a gene encoding a nuclear factor IRF-1 that specifically binds to IFN-β gene regulatory elements
33. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome
34. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses
35. The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes
36. Construction, arraying, and high-density screening of large insert libraries of human chromosomes X and 21: their potential use as reference libraries
37. Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS
38. The Wiskott-Aldrich syndrome studies of lymphocytes granulocytes and platelets
39. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells
40. Defective lymphocyte transformation and delayed hypersensitivity in Wiskott-Aldrich syndrome
41. Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome
42. An “attenuator domain” is sandwiched by two distinct transactivation domains in the transcription factor C/EBP
43. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome
44. A prolinerich transcriptional activation domain in murine HOXD-4 (HOX-42)
45. Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome
46. Expression on blood cells of sialophorin the surface glycoprotein that is defective in Wiskott-Aldrich syndrome
47. A novel rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones
48. A family of human CCAAT-box-binding proteins active in transcription and DNA replication cloning and expression of multiple cDNAs
49. Report of the fourth international workshop on human X chromosome mapping 1993
50. Molecular characterization of sialophorin (CD43) the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome
51. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome
52. Frameshift mutations in the v-src gene of avian sarcoma virus act in cis to specifically reduce v-src mRNA levels
53. Inherited thrombocytopenia elevated serum IgA and renal disease identification as a variant of the Wiskott-Aldrich syndrome
54. Functional dissection of VP16 the trans-activator of herpes simplex virus immediate early gene expression
55. Structural basis for the binding of proline-rich peptides to SH3 domains